Keyword: Turku PET Centre

University of Turku Professors Johanna Ivaska and Lauri Nummenmaa have received significant research funding from the European Research Council ERC. Ivaska received funding for a project that aims to discover how the biological limits of a healthy body influence cancer progression. Nummenmaa’s project examines the link between a person’s negative emotions and their physical well-being.

AI4HOPE, a groundbreaking initiative funded by Horizon Europe, is leading the charge in transforming dementia care through cutting-edge digital health interventions. With a mission to revolutionise support for individuals with dementia and their caregivers, AI4HOPE aims to reduce distress and anxiety while enhancing the overall quality of life.

In the context of the 33rd BioCity Symposium (29-30 August 2024) the twentieth Elias Tillandz prize will be awarded for the best scientific paper published in 2023 in Turku.

A new study of the Turku PET Centre in Finland has shown that music evokes similar emotions and bodily sensations around the world.

The first Turku Imaging Day will take place in Turku on October 3rd. The day will bring together the imaging community of Turku's universities, which may be unexpectedly large. "Almost 100% of researchers in life sciences use imaging in their work," says Research Manager Pasi Kankaanpää of the Turku Faculty of Medicine.

Frontiers of Science Seminar program is ready for autumn 2023. All seminars are on-site only at 12:00 in BioCity, Presidentti auditorium. Coffee and sandwich is served before each seminar.

A new study from Turku PET Centre and Åbo Akademi University has revealed that orgasm releases endogenous opioids in the human brain.

Registration to BioCity Symposium is open until 11 August 2023. BioCity Symposium is one of the most important meetings in Turku region for researchers working in the fields of bio- and molecular medicine. This year the event is arranged with title Sculpting tissues – Cells, matrix and forces.

In a study conducted at the University of Turku, Finland, the neural mechanisms of different anesthetics were investigated using functional brain imaging. Disconnection from external world and events ("being asleep") was specifically related to reduced activity in the central thalamic nuclei in subjects who received propofol, dexmedetomidine or sevoflurane, but not in subjects who received S-ketamine.

Folate-based radiopharmaceuticals can be used in positron emission tomography (PET) imaging to detect folate receptors in brain tumours. The discovery of folate receptors and their exploitation potential with respect to brain tumours is a new and significant finding in the field.